Locations:
Search
Identifying candidates for further screening and treatment
Daily five-fraction partial breast irradiation (PBI) shows similar acute and late toxicity as every other day PBI
Screening also found to be cost-effective
Research highlights promising outcomes for treating recurrent and metastatic cases
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Correlation found between the biomarker HSD3B1 and resistance to combined hormone therapy and radiotherapy
Meta-analysis suggests efficacy and safety
New research from Cleveland Clinic helps explain why these tumors are so refractory to treatment, and suggests new therapeutic avenues
Transperineal ultrasound a viable, non-invasive option for monitoring intra-fractional prostate motion
Multidisciplinary team to examine radiation therapy combined with immunotherapy
Preoperative treatment ensures successful surgical resection
Advertisement
Advertisement